Literature DB >> 15731024

Vibrio parahaemolyticus disruption of epithelial cell tight junctions occurs independently of toxin production.

Tarah Lynch1, Scott Livingstone, Enrico Buenaventura, Erika Lutter, Jason Fedwick, Andre G Buret, David Graham, Rebekah DeVinney.   

Abstract

Vibrio parahaemolyticus is a leading cause of seafood-borne gastroenteritis worldwide. Virulence is commonly associated with the production of two toxins, thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH). Although the majority of clinical isolates produce TDH and/or TRH, clinical samples lacking toxin genes have been identified. In the present study, we investigated the effects of V. parahaemolyticus on transepithelial resistance (TER) and paracellular permeability in Caco-2 cultured epithelial cells. We found that V. parahaemolyticus profoundly disrupts epithelial barrier function in Caco-2 cells and that this disruption occurs independently of toxin production. Clinical isolates with different toxin genotypes all led to a significant decrease in TER, which was accompanied by an increased flux of fluorescent dextran across the Caco-2 monolayer, and profound disruption of actin and the tight junction-associated proteins zonula occludin protein 1 and occludin. Purified TDH, even at concentrations eightfold higher than those produced by the bacteria, had no effect on either TER or paracellular permeability. We used lactate dehydrogenase release as a measure of cytotoxicity and found that this parameter did not correlate with the ability to disrupt tight junctions. As the effect on barrier function occurs independently of toxin production, we used PCR to determine the toxin genotypes of V. parahaemolyticus isolates obtained from both clinical and environmental sources, and we found that 5.6% of the clinical isolates were toxin negative. These data strongly indicate that the effect on tight junctions is not due to TDH and suggest that there are other virulence factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731024      PMCID: PMC1064919          DOI: 10.1128/IAI.73.3.1275-1283.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Vibrio parahaemolyticus thermostable direct hemolysin can induce an apoptotic cell death in Rat-1 cells from inside and outside of the cells.

Authors:  R Naim; I Yanagihara; T Iida; T Honda
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

2.  Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.

Authors:  I Simonovic; J Rosenberg; A Koutsouris; G Hecht
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

Review 3.  Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens.

Authors:  C L Sears
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-12       Impact factor: 4.052

4.  Environmental investigations of Vibrio parahaemolyticus in oysters after outbreaks in Washington, Texas, and New York (1997 and 1998).

Authors:  A DePaola; C A Kaysner; J Bowers; D W Cook
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

5.  Enterotoxicity and cytotoxicity of Vibrio parahaemolyticus thermostable direct hemolysin in in vitro systems.

Authors:  F Raimondi; J P Kao; C Fiorentini; A Fabbri; G Donelli; N Gasparini; A Rubino; A Fasano
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Mechanisms of chloride secretion induced by thermostable direct haemolysin of Vibrio parahaemolyticus in human colonic tissue and a human intestinal epithelial cell line.

Authors:  A Takahashi; Y Sato; Y Shiomi; V V Cantarelli; T Iida; M Lee; T Honda
Journal:  J Med Microbiol       Date:  2000-09       Impact factor: 2.472

7.  Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins.

Authors:  A Nusrat; C von Eichel-Streiber; J R Turner; P Verkade; J L Madara; C A Parkos
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin.

Authors:  K J Fullner; J J Mekalanos
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

9.  Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus.

Authors:  Kwon-Sam Park; Takahiro Ono; Mitsuhiro Rokuda; Myoung-Ho Jang; Tetsuya Iida; Takeshi Honda
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

10.  Effect of pH on the production of the Kanagawa hemolysin by Vibrio parahaemolyticus.

Authors:  J W Cherwonogrodzky; A G Clark
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

View more
  28 in total

Review 1.  Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants.

Authors:  G Balakrish Nair; Thandavarayan Ramamurthy; Sujit K Bhattacharya; Basabjit Dutta; Yoshifumi Takeda; David A Sack
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2.

Authors:  Greta Caburlotto; Maria M Lleò; Tamara Hilton; Anwar Huq; Rita R Colwell; James B Kaper
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  Presence of pathogenic Vibrio parahaemolyticus in waters and seafood from the Tunisian Sea.

Authors:  Sadok Khouadja; Elisabetta Suffredini; Matteo Spagnoletti; Luciana Croci; Mauro M Colombo; Bakhrouf Amina
Journal:  World J Microbiol Biotechnol       Date:  2013-02-21       Impact factor: 3.312

4.  Phylogenetic and Biogeographic Patterns of Vibrio parahaemolyticus Strains from North America Inferred from Whole-Genome Sequence Data.

Authors:  John J Miller; Bart C Weimer; Ruth Timme; Catharina H M Lüdeke; James B Pettengill; DJ Darwin Bandoy; Allison M Weis; James Kaufman; B Carol Huang; Justin Payne; Errol Strain; Jessica L Jones
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

5.  Vibrio parahaemolyticus infection induces modulation of IL-8 secretion through dual pathway via VP1680 in Caco-2 cells.

Authors:  Takaaki Shimohata; Masayuki Nakano; Xin Lian; Tomomi Shigeyama; Hitomi Iba; Akiko Hamamoto; Masaki Yoshida; Nagakatsu Harada; Hironori Yamamoto; Masayuki Yamato; Kazuaki Mawatari; Toshiaki Tamaki; Yutaka Nakaya; Akira Takahashi
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

6.  Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1.

Authors:  Takahiro Ono; Kwon-Sam Park; Mayumi Ueta; Tetsuya Iida; Takeshi Honda
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 7.  Vibrio parahaemolyticus cell biology and pathogenicity determinants.

Authors:  Christopher A Broberg; Thomas J Calder; Kim Orth
Journal:  Microbes Infect       Date:  2011-07-07       Impact factor: 2.700

8.  Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system.

Authors:  Timothy Casselli; Tarah Lynch; Carolyn M Southward; Bryan W Jones; Rebekah DeVinney
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Characterization of the 5'-flanking region and regulation of expression of human anion exchanger SLC26A6.

Authors:  Seema Saksena; Alka Dwivedi; Amika Singla; Ravinder K Gill; Sangeeta Tyagi; Alip Borthakur; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

10.  Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin.

Authors:  Rongzhi Wang; Sui Fang; Dinglong Wu; Junwei Lian; Jue Fan; Yanfeng Zhang; Shihua Wang; Wenxiong Lin
Journal:  Appl Environ Microbiol       Date:  2012-05-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.